Mrv0541 02231216482D 17 18 0 0 1 0 999 V2000 1.8500 2.0625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.5645 2.4750 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 3.2789 2.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2789 1.2375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.9934 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.7079 1.2375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.9934 0.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.2789 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2789 -1.2375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.5645 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5645 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7798 1.0799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2949 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7798 -0.2549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5645 3.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.8500 3.7125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.2789 3.7125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 6 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 4 5 1 0 0 0 0 5 6 2 0 0 0 0 5 7 1 0 0 0 0 7 8 1 0 0 0 0 8 9 2 0 0 0 0 8 10 1 0 0 0 0 10 11 2 0 0 0 0 4 11 1 0 0 0 0 11 12 1 0 0 0 0 12 13 1 0 0 0 0 13 14 1 0 0 0 0 10 14 1 0 0 0 0 2 15 1 0 0 0 0 15 16 1 0 0 0 0 15 17 2 0 0 0 0 M END > DB03240 > drugbank > N[C@@H](CN1C2=C(CCC2)C(=O)NC1=O)C(O)=O > InChI=1S/C10H13N3O4/c11-6(9(15)16)4-13-7-3-1-2-5(7)8(14)12-10(13)17/h6H,1-4,11H2,(H,15,16)(H,12,14,17)/t6-/m0/s1 > VSGUEKZRMJVQOH-LURJTMIESA-N > C10H13N3O4 > 239.2279 > 239.090605919 > 5 > 30 > -0.03297616198428504 > 22.47383516339342 > 1 > 3 > 0 > 0 > (2S)-2-amino-3-{2,4-dioxo-1H,2H,3H,4H,5H,6H,7H-cyclopenta[d]pyrimidin-1-yl}propanoic acid > -1.50 > -3.343251458190551 > -0.97 > 0 > 0 > 2 > 0 > 10.297339335948765 > 1.9194953254057905 > 8.474158645678132 > 112.73000000000002 > 57.54370000000001 > 3 > 1 > 2.54e+01 g/l > tetrahydrofolic acid > 0 > DB03240 > EXPT01007 > experimental > (S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid $$$$